SPRC Bathi mangsa ngarep SciSparc Ltd.

SciSparc Ltd (SPRC) - logo korporat

The net profit forecast for SciSparc Ltd (SPRC) on GURU.Markets illustrates the trend of expectations, where serves as the current parameter value. The prospects for SciSparc Ltd depend on the success of cannabinoid tests for dementia and Tourette syndrome. A lack of seasonality and macro-resilience protect the business from market downturns. The company is currently in the pre-commercial stage, allocating capital strictly to fixed scientific protocols.

SciSparc Ltd (SPRC): Bathi forward saka 04.07.2022 nganti 17.11.2026

Rincian metrik lan analitis perusahaan Clearmind Medicine (SPRC)

- rega saham lan konsensus proyeksi valuasi:
Analisis komprehensif perusahaan:SciSparc, SPRC
Produk merek SciSparc Ltd.

This indicator determines the estimated net profit based on compromise closing prices of trading sessions. Investors utilize this metric to filter out market noise and assess objective capitalization potential. By analyzing the expected financial results of the company, one can identify the balance between asset stability and the potential for rapid growth. For SciSparc Ltd (SPRC), the profit forecast depends directly on the commercial success of its CNS therapy. Innovations in the treatment of Alzheimer's and Tourette's diseases form the foundation of the issuer's future profitability.